The use of nanomedicines in the healthcare systems: A policy brief DOI

Somayeh Vandghanooni,

Mehdi Jaymand, Morteza Eskandani

и другие.

Drug Development and Industrial Pharmacy, Год журнала: 2025, Номер unknown, С. 1 - 17

Опубликована: Апрель 5, 2025

ObjectiveNanomedicine is the application of nanotechnology to medicine and, therefore, a potentially transformative approach healthcare. This new and interdisciplinary field has three main applications in diagnostics, controlled/targeted drug delivery, regenerative medicine. Nanomedicine great potential change human health by advancing diagnosis, prevention treatment for wide variety diseases, including cancer, cardiovascular conditions, neurological disorders. Despite overwhelming potential, there are some issues impeding complete integration nanomedicines into healthcare systems.SignificanceThis policy brief addresses such critical inform guide decision-making on effectively deploying nanomedicine improve patient outcomes advance important public initiatives. In addition, prospects were also presented future.Key findingsThese brand-new nanosystems have serious drawbacks regard safety, efficacy, regulatory compliance, not mention acceptance. Nanomaterials can be so complex that their manufacturing processes become complex, which may bring question long-term effects environment. It discusses current barriers application, particularly regarding hurdles production robust clinical evidence.ConclusionsThis identifies key considerations policymakers stakeholders, highlighting requirement among researchers, clinicians, bodies. To facilitate safe successful care, continued collaboration imperative. Priority future should given developing comprehensive frameworks, raising awareness, promoting research resolve existing challenges unlock sector.

Язык: Английский

Dual-sided centripetal microgrooved poly (D,L-lactide-co-caprolactone) disk encased in immune-regulating hydrogels for enhanced bone regeneration DOI Creative Commons
You Wu, Xiaokun Yue, Ying Zhang

и другие.

Materials Today Bio, Год журнала: 2025, Номер 30, С. 101436 - 101436

Опубликована: Янв. 5, 2025

Well-designed artificial scaffolds are urgently needed due to the limited self-repair capacity of bone, which hampers effective regeneration in critical defects. Optimal must provide physical guidance recruit cells and immune regulation improve regenerative microenvironment. This study presents a novel scaffold composed dual-sided centripetal microgrooved poly(D,L-lactide-co-caprolactone) (PLCL) film combined with dynamic hydrogel containing prednisolone (PLS)-loaded Prussian blue nanoparticles (PB@PLS). The microgrooves on surface PLCL were imprinted using micropatterned polydimethylsiloxane (PDMS) template. Following aminolysis, was covalently grafted EM-7 peptide via glutaraldehyde. Functional group analysis, morphology hydrophilicity evaluated X-ray photoelectron spectroscopy (XPS), scanning electron microscopy (SEM), an optical contact angle measuring instrument, respectively. Bone regeneration-related (e.g., bone marrow mesenchymal stem cells, macrophages, Schwann endothelial cells) cultured films tended align along stripes migrate from periphery toward center region vitro. Subsequently, encapsulated immune-regulating synthesized thiol-modified gelatin Cu2+ presence PB@PLS nanoparticles, demonstrated excellent antioxidant properties. significantly accelerated critical-sized regeneration, as evidenced by increase volume newly formed histological images vivo. innovative approach holds substantial promise for clinical applications broader tissue repair.

Язык: Английский

Процитировано

19

Nanotechnology-based biomedical devices in the cancer diagnostics and therapy DOI
Junaid Tantray, Akhilesh Patel,

Hiba Parveen

и другие.

Medical Oncology, Год журнала: 2025, Номер 42(2)

Опубликована: Янв. 20, 2025

Язык: Английский

Процитировано

4

Liposomes as Immunotherapeutic Carriers: A Game-Changer in Cancer Therapy DOI

Sepehr Hoseinzadeh Moghaddam,

Abulfazl Vatankhah,

Fatemeh Oroojalian

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2025, Номер unknown, С. 106847 - 106847

Опубликована: Март 1, 2025

Язык: Английский

Процитировано

3

Biomimetic sodium alginate functionalized gold nanoparticles loaded with Trans-resveratrol for in-vitro cancer treatment and intercellular ROS studies against MCF-7 cell lines DOI
Yasir Iqbal, Faheem Amin,

Muhmmad Hammad Aziz

и другие.

Colloids and Surfaces A Physicochemical and Engineering Aspects, Год журнала: 2025, Номер unknown, С. 136448 - 136448

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

2

Overcoming Obstacles: The Role of Lipid Nanocarriers in Therapeutic Approaches for Pancreatic Cancer DOI
Md Sadique Hussain, Bhupendra G. Prajapati, Sonu Gandhi

и другие.

BioNanoScience, Год журнала: 2025, Номер 15(2)

Опубликована: Март 11, 2025

Язык: Английский

Процитировано

2

JAK/STAT signaling as a key regulator of ferroptosis: mechanisms and therapeutic potentials in cancer and diseases DOI Creative Commons

Yimeng Dai,

Chunguo Cui,

Dan Jiao

и другие.

Cancer Cell International, Год журнала: 2025, Номер 25(1)

Опубликована: Март 7, 2025

Ferroptosis is a distinct form of regulated cell death characterized by iron-dependent lipid peroxidation, playing critical role in various diseases, including cancer, neurodegeneration, and tissue damage. This study reviews the intricate relationship between ferroptosis Janus kinase/signal transducer activator transcription (JAK/STAT) signaling pathway, highlighting its regulatory functions across multiple biological processes. Dysregulation JAK/STAT pathway implicated promoting or inhibiting ferroptosis, depending on context. JAK2 promotes activating STAT proteins, modulating expression key regulators like SLC7A11 GPX4, influencing iron homeostasis through pathways such as ferritinophagy hepcidin regulation. STAT1 activation primarily enhances suppression cystine-glutamate antiporter (System Xc-), leading to glutathione depletion contributing conditions Sjogren's syndrome age-related macular degeneration. In contrast, STAT3 plays protective upregulating which inhibits survival, particularly cancers hepatocellular carcinoma, prostate renal carcinoma. also discusses STAT6's involvement diseases asthma lung injury regulating antioxidant defenses. Furthermore, review explores potential therapeutic strategies targeting manipulate for disease treatment. cancer therapy, this can enhance effectiveness inducers, offering promising avenues overcome drug resistance. Additionally, interplay immune responses, oxidative stress, metabolism underscores significance progression intervention. By exploring these mechanisms, provides insights into development novel treatments modulation, with implications inflammatory neurodegenerative conditions.

Язык: Английский

Процитировано

1

Prunin: An Emerging Anticancer Flavonoid DOI Open Access
Juie Nahushkumar Rana, Sohail Mumtaz

International Journal of Molecular Sciences, Год журнала: 2025, Номер 26(6), С. 2678 - 2678

Опубликована: Март 16, 2025

Despite the substantial advances in cancer therapies, developing safe and effective treatment methodologies is critical. Natural (plant-derived compounds), such as flavonoids, might be crucial a methodology without toxicity toward healthy tissues. Prunin flavonoid with potential to used biomedical applications. has yet undergo thorough scientific research, its precise molecular mechanisms of action remain largely unexplored. This review summarizes therapeutic prunin for first time, focusing on underlying an anticancer compound. gained significant attention due antioxidant, anti-inflammatory, effects. aims unlock how functions at level exert effects, primarily modulating key cellular pathways. Furthermore, we have discussed prunin’s adjunctive therapy conventional treatments, highlighting ability strengthen responses while decreasing drug resistance. Moreover, discussion probes into innovative delivery methods, particularly nanoformulations, that address bioavailability, solubility, stability limitations optimize application. By providing comprehensive analysis properties, this stimulate further exploration using agent, thereby progressing development targeted, selective, safe, methods.

Язык: Английский

Процитировано

1

Current Research in Drug-Free Cancer Therapies DOI Creative Commons

Akshaya Andavar,

Varsha Rajesh Bhagavathi,

J Cousin

и другие.

Bioengineering, Год журнала: 2025, Номер 12(4), С. 341 - 341

Опубликована: Март 26, 2025

Cancer treatment has historically depended on conventional methods like chemotherapy, radiation, and surgery; however, these strategies frequently present considerable limitations, including toxicity, resistance, negative impacts healthy tissues. In addressing challenges, drug-free cancer therapies have developed as viable alternatives, utilizing advanced physical biological to specifically target tumor cells while reducing damage normal This review examines several strategies, such high-intensity focused energy beams, nanosecond pulsed electric fields, photothermal therapy well the use of inorganic nanoparticles promote selective apoptosis. We also investigate significance targeting microenvironment, precision medicine, immunotherapy in progression personalized therapies. Although approaches demonstrate significant promise, challenges scalability, safety, regulatory obstacles must be resolved for clinical application. paper presents an overview current research therapies, emphasizing recent advancements, underlying scientific principles, steps required implementation.

Язык: Английский

Процитировано

1

Advances and applications of hyperthermia in tumor therapy: Mechanisms, techniques, and clinical integration DOI

Cui-Hua Gu,

Jinzhong Zhang, Jinsong Zeng

и другие.

International Communications in Heat and Mass Transfer, Год журнала: 2025, Номер 164, С. 108895 - 108895

Опубликована: Март 29, 2025

Язык: Английский

Процитировано

1

STAT3 Orchestrates Immune Dynamics in Hepatocellular Carcinoma: A Pivotal Nexus in Tumor Progression DOI

Ai-Guo Zhang,

H U Songbai,

Chuanzheng Yin

и другие.

Critical Reviews in Oncology/Hematology, Год журнала: 2025, Номер unknown, С. 104620 - 104620

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

1